CTLA4 and metastatic melanoma: Dubin et al. reported that increased representation of the phylum Bacteroidetes was associated with resistance to development of ICI-associated colitis in a study of metastatic melanoma patients treated with anti-CTLA-4 antibody [59], a finding that was later reproduced by another study [8].